| IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test T Bhattacharyya, A Ayandeh, AK Falconar, S Sundar, S El-Safi, ... PLoS neglected tropical diseases 8 (10), e3273, 2014 | 52 | 2014 |
| Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα N Liang, A Damdimopoulos, S Goñi, Z Huang, LL Vedin, T Jakobsson, ... Nature communications 10 (1), 1684, 2019 | 47 | 2019 |
| Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis T Bhattacharyya, DE Bowes, S El-Safi, S Sundar, AK Falconar, OP Singh, ... PLoS neglected tropical diseases 8 (2), e2675, 2014 | 44 | 2014 |
| Ezetimibe in combination with simvastatin reduces remnant cholesterol without affecting biliary lipid concentrations in gallstone patients O Ahmed, K Littmann, U Gustafsson, C Pramfalk, K Öörni, L Larsson, ... Journal of the American Heart Association 7 (24), e009876, 2018 | 38 | 2018 |
| Sex-specific lipid molecular signatures in obesity-associated metabolic dysfunctions revealed by lipidomic characterization in ob/ob mouse M González-Granillo, LA Helguero, E Alves, A Archer, C Savva, M Pedrelli, ... Biology of sex Differences 10, 1-17, 2019 | 37 | 2019 |
| Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis A Archer, J Laurencikiene, O Ahmed, KR Steffensen, P Parini, ... American Journal of Physiology-Endocrinology and Metabolism 306 (5), E494-E502, 2014 | 37 | 2014 |
| Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice O Ahmed, C Pramfalk, M Pedrelli, M Olin, KR Steffensen, M Eriksson, ... Digestive and Liver Disease 51 (7), 1016-1022, 2019 | 11 | 2019 |
| Cholinergic regulation of vascular endothelial function by human ChAT+ T cells L Tarnawski, VS Shavva, EJ Kort, Z Zhuge, I Nilsson, AL Gallina, ... Proceedings of the National Academy of Sciences 120 (14), e2212476120, 2023 | 10 | 2023 |
| Enzymatic quantification of liver lipids after folch extraction ME Minniti, O Ahmed, M Pedrelli Kupffer Cells: Methods and Protocols, 101-108, 2020 | 10 | 2020 |
| Soat2 ties cholesterol metabolism to β‐oxidation and glucose tolerance in male mice C Pramfalk, O Ahmed, M Pedrelli, ME Minniti, S Luquet, RGP Denis, ... Journal of Internal Medicine 292 (2), 296-307, 2022 | 7 | 2022 |
| Overexpression of transforming growth factor β induced factor homeobox 1 represses NPC1L1 and lowers markers of intestinal cholesterol absorption P Parini, TA Melhuish, D Wotton, L Larsson, O Ahmed, M Eriksson, ... Atherosclerosis 275, 246-255, 2018 | 6 | 2018 |
| Hepatic stellate cell activation markers are regulated by the vagus nerve in systemic inflammation O Ahmed, AS Caravaca, M Crespo, W Dai, T Liu, Q Guo, M Leiva, G Sabio, ... Bioelectronic Medicine 9 (1), 6, 2023 | 1 | 2023 |
| Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19 O Ahmed, AK Mukarram, C Pirazzini, EE Marasco, M Pedrelli, ME Minniti, ... Atherosclerosis 331, e143-e144, 2021 | 1 | 2021 |
| Statins regulate PNPLA3 through a mechanism that requires SREBF2 in human liver cells O Ahmed, VS Shavva, W Dai, L Tarnawski, S Malin, A Franco-Cereceda, ... Journal of Hepatology 78, S756-S757, 2023 | | 2023 |
| Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor and Pharmaceutical Use Therefor H Tomoda, T Nagamitsu, S Omura, P Parini, O Ahmed, M Pedrelli, ... US Patent App. 17/795,812, 2023 | | 2023 |
| Validation of network medicine interactomes: From patients to a human hepatocyte-like model F Grassi, D Dall'Olio, O Ahmed, C Sala, M Bersanelli, C Pramfalk, ... Atherosclerosis 355, 20, 2022 | | 2022 |
| Kupffer cells dictate hepatic responses to the atherogenic dyslipidemic insult S Hellberg, O Ahmed, Y Zhang, G Di Nunzio, HM Bjorck, R Francis, ... bioRxiv, 2022.10. 13.512086, 2022 | | 2022 |
| PRDs Are Multifunctional Oral Inhibitors of PCSK9 and ACAT2 P Paolo, O Ahmed, M Pedrelli, T Oshiro, C Pramfalk, M Eriksson, E Mejia Circulation 144 (Suppl_1), A10013-A10013, 2021 | | 2021 |
| Role of Cholesterol Metabolism in Hepatic Steatosis and Glucose Tolerance OSO Ahmed PQDT-Global, 2019 | | 2019 |
| Simvastatin and ezetimibe reduce plasma lipoprotein binding to human arterial proteoglycans in gallstone diseased patients K Littmann, O Ahmed, U Gustafsson, C Pramfalk, K Öörni, L Larsson, ... Atherosclerosis 275, e234, 2018 | | 2018 |
Camilla PramfalkKarolinska InstitutetVerified email at ki.se
